Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001641172-25-006102
Filing Date
2025-04-25
Accepted
2025-04-25 08:00:20
Documents
24
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm   iXBRL DEF 14A 725046
2 formdef14a_001.jpg GRAPHIC 33386
3 formdefa_005.jpg GRAPHIC 726220
4 formdef14a_002.jpg GRAPHIC 26005
5 formdef14a_003.jpg GRAPHIC 39381
6 formdef14a_004.jpg GRAPHIC 38196
7 proxy_001.jpg GRAPHIC 278801
8 proxy_002.jpg GRAPHIC 271904
  Complete submission text file 0001641172-25-006102.txt   4979539

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE hrow-20241231.xsd EX-101.SCH 6276
10 XBRL DEFINITION FILE hrow-20241231_def.xml EX-101.DEF 11052
11 XBRL LABEL FILE hrow-20241231_lab.xml EX-101.LAB 66836
12 XBRL PRESENTATION FILE hrow-20241231_pre.xml EX-101.PRE 43652
27 EXTRACTED XBRL INSTANCE DOCUMENT formdef14a_htm.xml XML 179289
Mailing Address 1A BURTON HILLS BLVD SUITE 200 NASHVILLE TN
Business Address 1A BURTON HILLS BLVD SUITE 200 NASHVILLE TN 615.733.4731
HARROW, INC. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35814 | Film No.: 25870030
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)